Please provide your email address to receive an email when new articles are posted on . The addition of eltrombopag to standard immunosuppressive therapy did not have a significant impact on response ...

HealthDay News — Recommendations for the diagnosis and management of severe acquired aplastic anemia are presented in a clinical practice guideline issued by the American Society of Hematology and ...

Please provide your email address to receive an email when new articles are posted on . Eltrombopag increased response rates when added to standard immunosuppressive therapy among patients with ...

Standard therapy for severe aplastic anemia entails immunosuppression with horse antithymocyte globulin plus cyclosporine. Early research suggested that adding eltrombopag to this regimen could ...

Severe aplastic anemia used to have few options and mortality was high, but a new class of drugs offers some hope. A recent review examined treatment options for aplastic anemia (AA), a hematopoietic ...

The American Society of Hematology (ASH) released guidelines on the diagnosis and management of severe acquired aplastic anemia, a rare and life-threatening bone ...

The European Society for Blood and Marrow Transplantation (EBMT), Europe's collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced ...

The European Society for Blood and Marrow Transplantation (EBMT), Europe's collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced ...

Over the past three decades, efforts to improve the results of standard treatment for patients with Severe Aplastic Anemia have been largely unsuccessful. The phase III RACE trial, sponsored by the ...

Dr. Timothy Olson, a pediatric hematologist at Children's Hospital of Philadelphia, discusses the most current thinking on treatment of children with aplastic anemia. This video was recorded at the ...